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Rezumat
Efectul diabetului zaharat asupra evoluţiei clinice a pancreatitei 
cronice conform clasifi cării M-ANNHEIM
Pancreatita cronică este o boală difi cil de diagnosticat şi de tratat. 
Scopul studiului a fost de a evalua severitatea pancreatitei cronice prin 
clasifi carea M-ANNHEIM conform prezenţei insufi cienţei pancreatice 
endocrine. Au fost analizate prezenţa insufi cienţei pancreatice excre-
torii şi incretorii, schimbările structurale ale pancreasului prin ultra-
sonografi e, coprogramă, nivelul de hemoglobină glicozilată în sânge, 
numărul complicaţiilor la 38 de pacienţi cu PC(grupul 1) şi pancreatită 
cronică asociată cu diabet (grupul 2). Corelaţia strânsă dintre gradul 
de severitate al PC în clasifi carea M-ANNHEIM şi criteriile obiective 
de leziuni cronice ale pancreasului demonstrează informativitatea sa 
înaltă, care este noutatea studiului nostru. 
Cuvinte-cheie: pancreatită cronică, diabet zaharat, clasificare 
M-ANNHEIM, grad al pancreatitei cronice
Резюме
Влияние сахарного диабета на клиническое течение и тя-
жесть хронического панкреатита в соответствии со шкалой 
M-ANNHEIM
Хронический панкреатит (ХП) относится к заболеваниям, кото-
рые сложно диагностировать и лечить. Целью исследования было 
оценить тяжесть хронического панкреатита в соответствии 
с классификацией M-ANNHEIM в зависимости от эндокринной 
недостаточности поджелудочной железы (ПЖ). Были проана-
лизированы: структурные изменения ПЖ по ультразвуковым кри-
териям, копрограмма, уровень гликозилированного гемоглобины, 
частота осложнений у 38 больных ХП без и с сопутствующим 
сахарным диабетом. Была выявлена тесная корреляция между 
тяжестью ХП по классификации M-ANNHEIM и объективными 
критериями хронического поражения поджелудочной железы. 
Наличие эндокринной недостаточности ПЖ осложняло тяжесть 
заболевания в соответствии со шкалой  M-ANNHEIM, коррелируя 
с нарушениями копрограммы (r=0.702; p<0.001), ультразвуковыми 
критерияи (r=0.55; p<0.05), уровнем гликозилированного гемогло-
бины (r=0.678; p<0.01).
Ключевые слова: хронический панкреатит, сахарный диабет, 
шкала M-ANNHEIM 
Introduction
Chronic pancreatitis (CP) is the disease difficult to diagnose 
and treat. This is due to the low sensitivity of the tests and func-
tional imaging techniques pancreas. The problem of diagnosing 
chronic pancreatitis cannot be considered solved. CP remains 
a difficult problem of clinical medicine and surgery, as in many 
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cases accompanied by severe complications and 
fatal. This is obviously due to the fact that CP is pol-
yetiological disease because in its development play 
role several reasons [1]. Among them, there are the 
most important external toxins, metabolic changes, 
mediated immune factors, congenital and acquired 
pancreatic duct structure and others. [2]. Secretory 
and incretory sections of pancreas damaged at the 
CP, which leads to the concomitant diabetes mellitus 
(DM) on the later stages, course of which in this di-
sease is studied insufficiently. It occurs in 10-90% of 
patients with CP [5, 8]. Such a large difference of the 
literature data about the frequency of diabetes in CP 
is associated with a different probability of endocrine 
disruption in various forms of pancreatitis [4, 7]. 
For today the evaluation criteria of the CP and 
CP with concomitant diabetes severity, depending 
on the severity of violations of excretory and increto-
ry function of pancreas remain unclear until the end. 
In the world practice, to explore the severity of CP the 
scoring system M-ANNHEIM has been successfully 
used, which takes into account the multiplicity of 
the risk factors for CP [3]. Multifactor classification 
M-ANNHEIM is simple, objective, accurate, does not 
demand many invasive diagnostic methods that take 
into account the etiology, disease stage and severity 
of the clinical course, which opens new perspectives 
of a wider application in practice of the family doctor. 
The causal nature of the CP manifestations based on 
the clinical stage, disturbance of endo- and exocrine 
functions of the pancreas on the background DM, 
frequent and severity of complications are shown in 
the works [9, 10]. The evaluation of the CP severity by 
the M-ANNHEIN system [11, 12] considered only the 
severity and frequency of the pain syndrome mani-
festations and do not take into account the presence 
of concomitant DM with the development incretory 
and excretory insufficiency of the pancreas.
The purpose of the research was to assess the 
severity of chronic pancreatitis by the classification 
of M-ANNHEIM according to availability of endocrine 
pancreatic insufficiency. 
Patients and methods
Were examined 38 patients (19 men and 19 
women) with a diagnosis of CP, from them – 19 with 
CP and 19 – with CP and DM. The average age was 
49.8 ± 2.2 years. The average age of patients with 
CP was 45.3 ± 3.4 years (8 men and 11 women), and 
patients with CP and DM – 54.4 ± 2.5 years (11 men 
and 8 women). The diagnosis of CP and DM was 
verified in accordance with the generally accepted 
criteria in the clinic [6].
CP severity was assessed by the system M-ANN-
HEIM based on the clinical stage and severity index. 
It was analyzed the presence of excretory and incre-
tory pancreatic insufficiency, structural changes of 
the pancreas by ultrasound criteria, coprogram, the 
level of glycosylated hemoglobin in the blood, the 
number of complications.  Evaluation of the copro-
gram conducted by increasing the number of muscle 
fibers, fiber that is digested, fatty acids, neutral fat, 
white blood cells, the appearance of mucus helmin-
thic eggs. Each pathological feature was estimated 
as 1 point. Statistical significance of differences was 
assessed by averages Student t-criteria (p < 0.05).
Results
Patients were divided into 2 groups: patients 
with CP and CP with concomitant diabetes. By clas-
sifying M-ANNHEIM all patients belonged to the 
diagnostic category “defined” CP. 16 of the 38 study 
patients (42.11%) had II B, 3 patients (7.89%) – II C, 15 
patients (39.47%) - III A and 4 patients (10.53%) – III 
B clinical stage.
Learning pain syndrome in the study patients 
showed that in 42.10% of patients with CP pain 
stopped when taking analgesics (2 points). In 52.64% 
pain had a recurring character, which corresponded 
to 3 points. There were times when pain was absent, 
regardless of the presence or absence of drug treat-
ment in 5.26% of patients with CP – pain consistent 
with both 2 and 3 balls. At 21.05% of patients with 
CP with concomitant DM the pain abated after ad-
ministration of analgesics (2 points) and in 78.95% 
of patients the pain had a recurring character, which 
corresponded to 3 points. Control of pain was asses-
sed according to the classification of M-ANNHEIM 
in 1 point in all patients (100%), since all patients 
received narcotic analgesics.
Surgical treatment performed in 10.53% of 
patients with CP, and in patients with CP with conco-
mitant DM – 26.31%, and two of them were carried 
out repeated operations.
In the most patients with CP with concomitant 
DM – 57.89% – proven exocrine insufficiency was 
observed, which corresponded to 2 points, in 42.11% 
– the presence of moderate exocrine insufficiency 
which did not need replacement enzyme therapy 
(1 point). In patients with CP 84.21% had proven 
– (2 points) and 15.79% – mild (1 point) – exocrine 
insufficiency. Patients without failure of pancreas 
functions in the research were not present.
Endocrine insufficiency was assessed in the 
absence or presence of DM and was found in 100% 
of CP with concomitant DM.
According to the ultrasound criteria, in 73.68% 
with CP revealed changes in the structure of the 
pancreas, which corresponded to mild severity (2 
points for M-ANNHEIM), in 21.06% of patients – mo-
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derate severity (3 points). Significant changes in the 
structure of the pancreas by ultrasound criteria were 
noted in 5.26% of patients, which corresponded to 
severe severity (4 points). 57.89%  of patients with CP 
with concomitant DM with changes of  the structure 
of pancreas had mild severity (2 points), 42.11% of 
patients had moderate severity (3 points). In patients 
with CP and CP with diabetes complications were 
found, respectively, in 3 against 4 patients.
It was found 14 (73.68%) patients with CP with 
moderate (B) severity and 5 (26.32%) – with medium 
(C) severity by the M-ANNHEIM classification. Howe-
ver, among the patients with CP and DM were found 
2 (10.52%) patients with moderate (B) severity, 16 
(68.42%) – with medium (C) severity, 2 (10.53%) – 
with severe (D) severity and 2 (10.53%) – with heavy 
(E) severity.
Analyzing the coprogram data, ultrasound 
data, glycosylated hemoglobin levels and points 
by M-ANNHEIM classification were found following 
changes that are shown in table. In patients with CP 
with concomitant DM coprogram changes were sig-
nificantly more important than in patients without 
DM (5.47 ± 0.21) against (4.73 ± 0.14) points. A similar 
trend was observed in relation to changes of the 
ultrasound criteria in points (5.26 ± 0.28) to (4.05 ± 
0.30) points. The level of glycosylated hemoglobin 
in patients with DM (7.16 ± 0.43) % was significantly 
higher than in the patients with CP without incretory 
failure (5.15 ± 0.20) %. The points by M-ANNHEIM 
classification in the 2nd group were significantly more 
important than in the first group (13.89±0.90) against 
(8.63±0.52) points.
In conducting the correlation and regression 
analysis were found direct correlations between 
the severity of chronic pancreatitis by M-ANNHEIM 
and changes of coprogram (r=0.702; p<0.001), ultra-
sound criteria (r=0.55; p<0.05), the level of glycosy-
lated hemoglobin (r=0.678; p<0.01).
Dynamics of coprogram changes, ultrasound criteria and 
the level of glycosylated hemoglobin in patients with chro-
nic pancreatitis and chronic pancreatitis with concomitant 
diabetes mellitus 
Indication
Groups of patients with CP
CP CP+DM
n=19 n=23
Coprogram, points 4.73±0.14 5.47±0.21*
Ultrasound criteria, points 4.05±0.30 5.26±0.28*
Glycosylated hemoglobin, % 5.15±0.20 7.16±0.43*
Points by M-ANNHEIM 8.63±0.52 13.89±0.90*
Note: * – р<0.05
Quantitative criteria for the M-ANNHEIM clas-
sification are easy to use, can be easily incorporated 
into practice of general practitioner that will provi-
de dynamic observation of the patient, timeliness 
of the application is not only therapeutic but also 
prophylactic programs in the conditions of clinical 
examination and routine supervision proved in terms 
of their use in clinical practice.
Conclusions
1. The close correlation between CP severity 
by M-ANNHEIM classification and objective criteria 
of chronic lesions of the pancreas demonstrate its 
high information content, which is the novelty of 
our study. The presence of endocrine insufficiency of 
pancreas in the way of diabetes mellitus complicated 
a clinical course of chronic pancreatitis according 
to the M-ANNHEIM scoring system, that correlated 
with the changes of coprogram (r=0.702; p<0.001), 
ultrasound criteria (r=0.55; p<0.05), the level of gly-
cosylated hemoglobin (r=0.678; p<0.01).
2. For patients with chronic pancreatitis with 
concomitant diabetes mellitus, a CP degree was 
more expressed than in the case of chronic pancreati-
tis without endocrine insufficiency. Average severity 
(S) prevailed in 68.42% of patients in the 2nd group 
vs. 26.32% of the first group, cases of expressed and 
severe severity appeared. 
3. We consider recommending the use of 
M-ANNHEIM scoring system in gastroenterological 
practice, therapeutic institutions and practices of 
family physicians.
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